ClinicalTrials.gov Noncompliance By Industry Remains An FDA Concern
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite “concerted” communications efforts by FDA, only 47% of clinical trials sponsored by industry are listed on registry website. Oncology Division Director Pazdur tells a House hearing that industry reluctance confuses the agency, which acknowledges “limited” enforcement capabilities.